A recent study reported that cancer patients could be grouped into six immune infiltration subtypes [43], including C1 (wound healing), C2 (INF‐r dominant), C3 (inflammatory), C4 (lymphocyte depleted), C5 (immunologically quiet), and C6 (TGFβ dominant). The gene discussed is TGFB1; the disease is cancer.